Market Research Report
Healthcare BPO Market by Provider (RCM, Patient Care), Payer (Claims Repricing), Pharmaceutical (R&D, Manufacturing, Sales and Marketing Services (Forecasting, Performance Reporting)), Outsourcing Approaches, Models - Global Forecasts to 2022
|Published by||MarketsandMarkets||Product code||294351|
|Published||Content info||207 Pages
Delivery time: 1-2 business days
|Healthcare BPO Market by Provider (RCM, Patient Care), Payer (Claims Repricing), Pharmaceutical (R&D, Manufacturing, Sales and Marketing Services (Forecasting, Performance Reporting)), Outsourcing Approaches, Models - Global Forecasts to 2022|
|Published: October 4, 2017||Content info: 207 Pages||
The healthcare BPO market is expected to grow at a CAGR of 10.2% from 2017 to 2022, to reach USD 312.43 billion by 2022 from USD 191.68 billion in 2017. The need to reduce the rising healthcare costs and the implementation of the Patient Protection and Affordable Care Act (PPACA) are factors that compel payers and providers to outsource their business processes to low-cost countries in order to reduce operational costs. Patent cliffs, complex clinical trial protocols, and new reporting requirements are forcing pharmaceutical companies to outsource their R&D and manufacturing processes to other countries, which is driving the healthcare outsourcing market. On the other hand, the fear of losing visibility & control over business processes and reliability and data security & privacy concerns are the major factors expected to restrain market growth.
On the basis of provider service, the healthcare BPO market is segmented into revenue cycle management, patient enrollment, and patient care. In 2017, the revenue cycle management segment is expected to account for the largest share of the global healthcare BPO market. Growth in the revenue cycle management market can largely be attributed to factors such as decreasing reimbursements in the healthcare industry, reductions in the overall healthcare costs, initiatives undertaken by governments for implementing RCM solutions, and increasing expenditure by the healthcare IT industry.
On the basis of pharmaceutical services, the market is classified into manufacturing services, R&D services, and non-clinical services. In 2017, the manufacturing services segment is expected to account for the largest share of the market. The rising demand for new drugs and cost advantages of outsourcing are the key factors driving the growth of this segment.
By source geography, the US is expected to account for the largest share, followed by Europe, and RoW. It is the prime source for the outsourcing of healthcare services due to the mandatory implementation of ICD-10 codes and enactment of PPACA. The US also ranks high as a preferred location in cases where location and skill are more important than cost savings.
The key players in the healthcare BPO market are: Cognizant (US), Accenture (Ireland), Xerox (US), Genpact (Bermuda), TCS (India), and Infosys (India).
The healthcare BPO market in this report is segmented by payer services, provider services, pharmaceutical services, and region. The study tracks and analyzes competitive developments such as product launches, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the healthcare BPO market.
The report provides insights on the following pointers:
*Business Overview, Strength Of Product Portfolio, Business Strategy Excellence, Recent Developments might not be captured in case of unlisted companies.